MedTrace Logo

A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimulator System in Chronic Post Surgical Pain

NCT02335229 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-04-29

Study results available
· View outcomes & findings →

Summary

20-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic post surgical pain

Conditions

  • Chronic Post Surgical Pain

Interventions

DEVICE

Axium DRG Neurostimulator

Implantation with Axium DRG Neurostimulator

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335229 on ClinicalTrials.gov